AlphaQ Advisors LLC purchased a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 8,174 shares of the biopharmaceutical company’s stock, valued at approximately $235,000. A number of other hedge funds have also recently […] Read this story
